T1	Participants 106 232	One hundred twelve patients who sustained hyphema after blunt trauma were enrolled in a double-blind randomized clinical trial
T2	Participants 371 413	Fifty-six patients received an oral dosage
T3	Participants 508 519	56 patients
T4	Participants 662 669	patient
T5	Participants 999 1007	patients
T6	Participants 1029 1037	patients
T7	Participants 1140 1145	group
